9-95508351-G-C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBS1BS2

The NM_000264.5(PTCH1):​c.11C>G​(p.Ala4Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000379 in 1,212,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A4V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000041 ( 0 hom. )

Consequence

PTCH1
NM_000264.5 missense

Scores

3
5
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 3.15

Publications

2 publications found
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
PTCH1 Gene-Disease associations (from GenCC):
  • basal cell nevus syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • holoprosencephaly 7
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
  • holoprosencephaly
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.1459006).
BS1
Variant frequency is greater than expected in population eas. GnomAdExome4 allele frequency = 0.0000413 (44/1064888) while in subpopulation EAS AF = 0.00177 (44/24882). AF 95% confidence interval is 0.00135. There are 0 homozygotes in GnomAdExome4. There are 20 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAdExome4 at 44 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000264.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
NM_000264.5
MANE Select
c.11C>Gp.Ala4Gly
missense
Exon 1 of 24NP_000255.2Q13635-1
PTCH1
NM_001083603.3
MANE Plus Clinical
c.199-1752C>G
intron
N/ANP_001077072.1Q13635-2
PTCH1
NM_001354918.2
c.11C>Gp.Ala4Gly
missense
Exon 1 of 23NP_001341847.1A0A1W5YLI7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
ENST00000331920.11
TSL:5 MANE Select
c.11C>Gp.Ala4Gly
missense
Exon 1 of 24ENSP00000332353.6Q13635-1
PTCH1
ENST00000437951.6
TSL:5 MANE Plus Clinical
c.199-1752C>G
intron
N/AENSP00000389744.2Q13635-2
PTCH1
ENST00000468211.6
TSL:1
c.4-1752C>G
intron
N/AENSP00000449745.1A0A0C4DGJ5

Frequencies

GnomAD3 genomes
AF:
0.0000135
AC:
2
AN:
147964
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000200
Gnomad SAS
AF:
0.000211
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000413
AC:
44
AN:
1064888
Hom.:
0
Cov.:
33
AF XY:
0.0000395
AC XY:
20
AN XY:
506014
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
21884
American (AMR)
AF:
0.00
AC:
0
AN:
7632
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13180
East Asian (EAS)
AF:
0.00177
AC:
44
AN:
24882
South Asian (SAS)
AF:
0.00
AC:
0
AN:
20126
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
22510
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2798
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
909758
Other (OTH)
AF:
0.00
AC:
0
AN:
42118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000135
AC:
2
AN:
148072
Hom.:
0
Cov.:
32
AF XY:
0.0000277
AC XY:
2
AN XY:
72272
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40384
American (AMR)
AF:
0.00
AC:
0
AN:
15002
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3412
East Asian (EAS)
AF:
0.000201
AC:
1
AN:
4986
South Asian (SAS)
AF:
0.000211
AC:
1
AN:
4738
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66714
Other (OTH)
AF:
0.00
AC:
0
AN:
2046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Gorlin syndrome (2)
-
1
-
Hereditary cancer-predisposing syndrome (1)
-
1
-
Holoprosencephaly 7 (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.0075
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.21
T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.23
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.62
T
M_CAP
Pathogenic
0.97
D
MetaRNN
Benign
0.15
T
MetaSVM
Uncertain
-0.12
T
MutationAssessor
Benign
1.4
L
PhyloP100
3.2
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
-0.46
N
REVEL
Uncertain
0.33
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.053
T
Polyphen
0.0
B
Vest4
0.12
MutPred
0.14
Gain of relative solvent accessibility (P = 0.0166)
MVP
0.57
MPC
0.86
ClinPred
0.50
T
GERP RS
2.0
PromoterAI
-0.020
Neutral
Varity_R
0.26
gMVP
0.64
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs540045689; hg19: chr9-98270633; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.